Not Found

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

Google Maps

Charles Prince

Mary Coleman

Anne Mulcahy

William Perez

Alex Gorsky

Mark Weinberger

Mary Beckerle

Susan Lindquist

Dominic J. Caruso

Vice President, Finance and Chief Financial Officer

Eric Milledge

Company Group Chairman

William E Cohn

VP, Medical Device Companies, Johnson & Johnson

Imran Rahim

Director, Information Security & Risk Management - AP

Jason Brown

Postdoctoral Fellow

Jorge Rowe

Sales Manager

Alice Lin Fabiano

Director, Worldwide Corporate Giving

Steve Wrenn

SVP & Group CIO Global Supply Chain

Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.

Dreem is a neurotechnology company composed of sleep pioneers, a team of experts fascinated by science, technology and design.

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Suncayr has developed a UV-responsive sticker that tells you when your sunscreen is no longer protecting you, using a simple colour change.

CardioMEMS develops wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body.

MicroMass Communications is a healthcare communications agency.

Crucell researches and develops products and markets vaccines, proteins and antibodies for the treatment of infectious diseases.

Ci:z Holdings develops, manufactures and sale of cosmetics.

United States Investors (Top 10K)

Investors Active in Washington DC Metro Area

East Coast Companies With More Than $10M in Revenue (Top 10K)

East Coast Companies With More Than 50 Employees (Top 10K)

Johnson & Johnson's research and development, manufacturing, and sale of healthcare products include pharmaceuticals, medical devices, and diagnostics. The company aims to improve access and create healthier communities.

New Brunswick

New Jersey

United States

North America

Johnson & Johnson

Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy Français

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Skin Care Products Market is likely to grow at a CAGR of 3.6% through 2031, reaching US$ 241.5 billion

Protagonist takes center stage with Phase III fillip

Thrombectomy Devices Market Size to be Worth USD 2.2 Billion by 2032, with a Projected CAGR of 7%

Cleanup for the IL-23 class in ulcerative colitis as new drugs 'rapidly gained significant momentum': report

Sector Update: Health Care Stocks Edge Lower Wednesday Afternoon

TRexBio Announces $84 Million Series B

Allergy Treatment Market Sees Growth as Allergy Cases Surge Worldwide | Registering a CAGR of 6.3%

J&J Seeks FDA Approval for Impella ECP Heart Pump

Johnson & Johnson's Innovative Medicine division focuses on developing treatments for complex diseases in areas such as oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina.

Johnson & Johnson MedTech provides medical technology solutions, focusing on interventional solutions, orthopaedics, surgery, and vision, with an emphasis on precision and less invasive treatments.

Johnson & Johnson offers cataract surgery solutions, including intraocular lenses like the TECNIS Odyssey IOL, which aim to restore vision and reduce the need for glasses.

Johnson & Johnson is involved in cell therapy research, aiming to harness the immune system to target and treat cancer.

Johnson & Johnson is researching treatments for prostate cancer, focusing on blocking cancer cells from repairing their damaged DNA.

Johnson & Johnson MedTech provides diagnostic and treatment solutions for atrial fibrillation, including mapping catheters and ablation technologies.

United Kingdom

Europe

India

Asia

Germany

Switzerland

HTML5

Modernizr

Apache Server

F5 NGINX

Bootstrap

Akamai Intelligent Platform

.NET 4.5

Google Doubleclick

ClearSlide

Johnson & Johnson owns Xian-Janssen Pharmaceutical

Johnson & Johnson owns Veridex

Johnson & Johnson owns Tibotec

Johnson & Johnson owns Therakos

Johnson & Johnson owns Scios Inc

Johnson & Johnson owns OraPharma Inc. (acquired by JNJ)

Johnson & Johnson owns Omrix Biopharmaceuticals

Johnson & Johnson owns Noramco

Johnson & Johnson owns Neutrogena

Johnson & Johnson owns Mentor Worldwide

Pfizer is a global pharmaceutical company that develops, manufactures, and sells prescription medicines, vaccines, and consumer healthcare products.

Pfizer

Novartis is a multinational pharmaceutical company known for its research and development of innovative healthcare products, including prescription medicines, eye care products, and generic pharmaceuticals.

Novartis

Merck is a leading global healthcare company that focuses on developing innovative prescription medicines, vaccines, biologic therapies, and animal health products.

Merck

Johnson & Johnson is a global healthcare company that focuses on innovative medicine and medtech solutions to address complex diseases and improve patient outcomes. With a commitment to using their reach and size for good, the company aims to improve access and affordability to create healthier communities and make health and wellness accessible to everyone.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

news impact assignment basic	general	Mar 7, 2024 3:19 PM	642f893e
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	08a1b599
news processing daily refresh	general	May 21, 2024 2:57 AM	2c1dd66e
news impact assignment daily	general	May 21, 2024 5:06 PM	72be71f0
news processing basic	general	Mar 7, 2024 3:19 PM	988aab57
company summary	general
signals	general	Mar 7, 2024 3:19 PM	9bbdb051
crunchbase trigger	general	Nov 22, 2024 7:44 AM	240ce078
crunchbase profile	general	Nov 22, 2024 8:49 AM	7f96f6f0
li profile	general	Mar 7, 2024 3:19 PM	91af1523
translate crunchbase fundingrounds	general	Nov 22, 2024 11:00 AM	168a8ec2
peers	general	Mar 7, 2024 3:19 PM	4d269a89
news basic	general	Dec 4, 2024 2:13 PM	5e76937f
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:JNJ

Johnson & Johnson

Last Close

155.50

22/11 21:00

Market Cap

359.63B

Beta: -

Volume Today

5.56M

Avg: -